Year: 2022
Type: dissertation
Study design: Observational Study
Abstract: BACKGROUNDBloodstream infections (BSIs) cause significant morbidity and mortality in critically ill children, but the optimal antimicrobial treatment duration is understudied. Adequate treatment duration is important to prevent clinical failure and infection relapse but treating for too long increase patients’ risks for developing adverse drug events, superinfections, and selection for antimicrobial resistance. This thesis describes preparatory work completed to justify and inform the design of a randomized controlled trial to evaluate antibiotic treatment durations for critically ill children with BSIs. METHODS We conducted four studies as preparatory work for a future trial: 1. Clinician practice survey to determine self-reported recommendations for antimicrobial treatment duration; 2. Retrospective observational study to describe actual treatment durations received by critically ill children with BSIs; 3. Systematic review of non-inferiority pharmacotherapy trials to examine prevailing non-inferiority margins used for mortality outcomes; 4. Retrospective observational study using PELOD-2 as an outcome measure to compare progression of organ dysfunction between children who received early or delayed adequate antimicrobial therapy. RESULTS In our survey, 64% to 99% respondents recommended 10 days of therapy for BSIs, depending on underlying source of infection. In our observational study, the median treatment duration was 15 (IQR 11-25) days. Longer durations were associated with greater severity of illness and central nervous system infections. The median non-inferiority margin size for mortality in non-inferiority trials was a 9% (IQR 4.2%-10%) absolute risk difference or 1.5 (IQR 1.3-1.7) relative to baseline mortality risks. We did not find an association between 3-hour delays of adequate antimicrobial therapy and change in PELOD-2 scores (0.05, 95% CI -0.76 – 0.87, p=0.9) between days 1 and 5 from the index BSI. CONCLUSIONS We found self-reported and actual practice heterogeneity on BSI treatment durations, and clinical equipoise to support a trial of shorter versus longer antimicrobial treatment in critically ill children. Current non-inferiority margins for mortality outcomes in published trials are large and variable. The use of organ dysfunction as an outcome measure for BSI trials requires further study.
Source: TSpace (University of Toronto)
Author: Pong, Sandra
Institution: University of Toronto
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7132887045
